France / French Pharma in 2024: 5 Things to Know
With revenues projected to reach USD 27.01 billion in 2024, France’s pharma market is ranked fifth globally. Home to a number of well-established local pharma players and a sought-after destination…
World leader in the field of invitro diagnostics, bioMérieux has been providing diagnostic solutions for 50 years, and is now operating in more than 150 countries through 41 subsidiaries and a large network of distributors. bioMérieux Industry is a specific business unit of bioMérieux with dedicated R&D, marketing, and commercial resources.
Developing and Producing the largest range of microbial control solutions (reagents, instruments, software and services), bioMérieux Industry provides answers from sample preparation to final identification and typing of microorganisms. bioMérieux industry serves with its dedicated teams five main customer types:
bioMérieux is determined to continue to play a pioneering role by innovating and designing the diagnostics of the future to address the major challenges for public health worldwide.
Contact
bioMérieux Singapore PTE LTD
11 – Biopolis Way
Helios, Unit #10-04
138667 Singapore
(+65) 6801 6700
(+65) 6478 9501
With revenues projected to reach USD 27.01 billion in 2024, France’s pharma market is ranked fifth globally. Home to a number of well-established local pharma players and a sought-after destination…
France’s life sciences industry is falling behind its European neighbours, its growth deeply hampered, the French life sciences think tank G5 Santé claims, by abusive paybacks. While the government has…
Exor, led by Fiat brand heirs the Agnelli family, has signed a partnership agreement for an investment of EUR 833 million in the also family-owned French holding, Institut Mérieux, known…
Brijesh Sawlani, general manager for North ASEAN Thailand, Myanmar and Indochina at bioMérieux, discusses current opportunities for the Thai affiliate, the competitive landscape in Thailand, his key strategic objective to…
Multinational pharmaceutical companies are increasingly choosing Algeria as a base for their regional headquarters, despite the complexities of the local market. The representatives of Lilly, bioMérieux and Abbott in Algeria…
Nadia Oka-Bousbia of bioMérieux Algeria discusses the affiliate’s important role within Algeria’s fight against infectious diseases and the training of health managers, difficulties surrounding import restrictions, and the company’s constantly-evolving…
Rocío Mendez, country manager at bioMérieux Colombia, speaks about the many talents that make up the Colombian affiliate and explains how the company brings life-saving and innovative solutions to a…
The General Manager of bioMérieux Switzerland and Austria highlights the significance of Switzerland for the company’s regional cluster and furthermore explains how Switzerland contributes to the global development of the…
Renaud Jonquieres, Vice President Asia-Pacific of bioMérieux Industry, enthusiastically conveys the company’s scope and significance in the Asia-Pacific region, the competitive landscape, as well as the key strategic objective to…
Jean-Luc Bélingard, chairman of bioMérieux, reveals how the medical community in France has a unique profile, combining both clinical and technological experience, leading to what he describes as the best…
See our Cookie Privacy Policy Here
